Company: MBIO
Filing Date: 2025-01-22
Form Type: DEF 14C
Source: 0001104659-25-005251
Chunk: 1

Company: MUSTANG BIO, INC.
Filing Date: 2025-01-22
Form: DEF 14C
Chunk 1
---
4 (the “Inducement Letter”), with a certain institutional
investor (the “Investor”), and (B) that certain previously disclosed engagement letter, dated as of October 23, 2024 (the
“Engagement Letter’), with H.C. Wainwright & Co., LLC (the “Placement Agent”), in an amount equal to or in
excess of 20% of the number of shares of common stock outstanding immediately prior to the issuance of such warrants (collectively, the
“Warrant Share Issuance”), as described in further detail in the Information Statement.

The accompanying Information Statement is being furnished only to inform stockholders in accordance with Rule 14c-2 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the actions taken by Written Consent described in the Information Statement before the Warrant ShareIssuance takes effect. We are also furnishing the Information Statement to our
stockholders in satisfaction of the notice requirement under Section 228 of the General Corporation Law of the State of Delaware (“DGCL”).
Because the Written Consent of the Majority Holders satisfies all applicable stockholder voting requirements, the Board is not soliciting
your proxy or consent in connection with the matters discussed above. You are urged to read the Information Statement carefully and in
its entirety for further information regarding the Warrant Share Issuance.

On January 15, 2025, we effected
a 1-for-50 reverse stock split of our issued and outstanding common stock. The reverse stock split was effected by the filing of a certificate
of amendment (the “Amendment”) to our amended and restated certificate of incorporation, as amended, with the Secretary of
State of the State of Delaware, without any change to par value. The Amendment became effective upon such filing. No fractional shares
were issued in connection with the reverse stock split as all fractional shares were rounded down to the next whole share. All share
and per share amounts of our common stock listed in this Information Statement have not been adjusted to give effect to the reverse stock
split, as the items described herein were approved prior to the reverse stock split.

This Information Statement is first being mailed to you on or about January 22,
2025. The approval of Warrant Share Issuance will become effective on the 20 day after this definitive information statement
is mailed to our stockholders.

This is not a notice of special meeting of stockholders and no stock